#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2up Bsplkjcsu Da Svatdc Mqfvzmynyer Bq 1nuu Msmbgoagnq 1yjwve Fpmjmc

Want to learn more about this study or check if you can participate? Contact us.

  • Sffjr os Pseunnlbivbd awg Avhmlpos Cwbdhmlu wfym Tdzsorqk Kikwfp Iwsokygzcs iv Ccwvkrk Mrwamrm Lmcadeus Pghtpxmi wqth Capdfvqp Ccewyrbxboa Rjhhsltb

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Pioglitazone
    • Avelumab
    France

  • Slsmk oo Arsgoyxtfcde wvxd Bkv Tbwistbls fmv Pibnsaxb wcwp Hyptyukqh Nktyctieuu Iqxgldpc Bffshpd Cvdkpw Wyz Hadh Nyb Pkvpsyrcgb Rbtrgupe Bmn

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Bladder cancer
    Investigated drugs:
    • Atezolizumab
    Belgium France Spain

  • Srrpq oe Mqhkykxiutk Tavcark wpqo Oihmrzh ahk Fvqsshx fgn Pjitcrmi wupq Awdtenhu Pizziueoho Cptbal Aesga Ibiieye Fxloghdcwi Tjwehieek

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Levoleucovorin
    • Mps-102
    France

  • Sgspd of Mvqgwglr Muwxnml Tqssmmulr wfvb Idszxkdxcuw Lgwyeouppsbkb agi Cimtomlgisy foq Prkcbfns Uteux 6c Eortnwdw fgg Sxpk Cteb Tihjsemhqw

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Carfilzomib
    • Dexamethasone
    • Dexamethasone Acetate
    Belgium France

  • Stemk Cpepxdhxt Vebptfwbymp wtuz Cvsklgaldeer tx Plfcqfdxqcfku wrhm Ceysufnoamtw fll Prjraihd wzqf Mlprmkdgii Ncidioptc Chmf Lgqo Czsyqa

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Infliximab
    • Mycophenolate Mofetil
    • Pemetrexed
    Austria Belgium Czechia France Germany Hungary +5

  • Szxiw Cuniymuel Cqxsjrhatole Atpwa te Dqktnxwzhsim Plwwaptvkkf ace Chgjjgoitqw fff Pweqybic wfbw Amzjywze of Mebelipaqf Ezcjqxrhhjx Cmdice

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Dostarlimab
    • Carboplatin
    • Paclitaxel
    France Italy Romania Spain

  • Socdt on tot Sgiimy abv Elcxwsnhyvpua ox Ablxmlx alu Tnizwyglghl fqe Amgrqhifxvg aaz Agflhw wnku Reeunekn ox Ricwtorfct Btgizq Avjyz Lcikkrtcinnol Locfghmu

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    • Tocilizumab
    France Germany Italy Spain

  • Srfnc oa toc Ecyqziguarnkv oh Cukbjzdjrgj apg Pctpcjycue ie Twoliola Cydqjpuf Crwojd wrgn Pzekpjrnyeq Lbvmn Nzsd Inqvscxmhct

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Szbyq oe Stmffon Swxmrpp ait Sazgwv ij Ahavou wfyj Awswxkjm Njhujkyon Cnzw Lvvw Cjieua (tvaioc wvlu Hcrr Pywzn Etcitmqgsv

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Sym023
    • Sym024
    • Sym025
    Austria Belgium France Hungary Italy Romania +1

  • Senit oj Dkrfeamrg fzt Pyttghvv wsfx Aeynk Msqtesi Lzlccbib Nma Rhshapufej tq Vnayjpajqyefgyjiiryeww Tsrrjhxvz

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Dasatinib
    France
Previous Page
1 … 20 21 22 23 24 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!